I agree that RVX is a "wait and see" stock.

Nice to finally see some life here. I check this site once or twice a month.

The stock seems to have settled in the $2 to $3 range, and a lot depends on the outcome of the current trials. If positive, there should be a significant boost to the share price. At some point, I would expect the current makers of Lipitor (Pfizer) or Chrestor (AstraZeneca) or others to get involved, through license, partnership, or takeover. I am not an expert but it seems to me that these statin drugs could become obsolete, and, personally, I would love to stop taking Lipitor. Successful "reverse transport" of cholesterol without the various side effects of statins will be a huge achievement.

There could be tremendous upside to the share price.

Deke

PS: Happy New Year!